Evaxion Reveals Innovative AI-Immunology™ Cancer Vaccine Concept

Proof of Concept – Evaxion’s AI-Immunology™ platform demonstrates success in designing precision cancer vaccines in hematological cance...

November 28, 2023 | Tuesday | News
Spineway Expands Global Reach with VEOS Implant Rollout in Spain, Colombia, and Indonesia

Successful First Implants in Spain, Accelerating Market Penetration New Approvals in Colombia and Indonesia Boost Sales Prospects Spineway Advances as ...

November 27, 2023 | Monday | News
Fapon Accelerates the Development of its Diagnostic Ecosystem

With a steadfast dedication of 22 years to advancing the fundamental technologies of raw materials, reagent and instrument, Fapon strives to empower the gl...

November 24, 2023 | Friday | News
STADA strikes partnership with CR Sanjiu in China to drive growth of its cough and cold portfolio

Partnership agreement signed on 22 November to broaden distribution and promotion of cough and cold brands such as Shidagong, Gelite and Ruike in China&n...

November 24, 2023 | Friday | News
Novo Nordisk Invests Over DKK 16 Billion in Chartres Production Expansion

The investment will significantly increase the capacity of the manufacturing site, adding aseptic production and finished production processes and an exten...

November 24, 2023 | Friday | News
Bracco's Strategic Partnership with ulrich medical for Syringeless MRI Injectors

Bracco, a global leader in diagnostic imaging, and ulrich GmbH & Co. KG, a renowned German medical device manufacturer specializing in contrast media i...

November 23, 2023 | Thursday | News
Syncona to Acquire Freeline Therapeutics

Freeline shareholders to receive $6.50 per American Depositary Share, a 51% premium over closing price prior to announcement of Syncona’s initial pro...

November 23, 2023 | Thursday | News
Hovione Acquires ExtremoChem for Enhanced Biopharmaceutical Stabilization and Delivery

Hovione has acquired ExtremoChem Lda, a start-up company with a portfolio of rare sugars, synthetic analogues of the natural molecules found in extremoph...

November 21, 2023 | Tuesday | News
Medtronic announces FDA approval of minimally invasive device to treat hypertension

Approval is the culmination of ten years of clinical research and development of the Medtronic renal denervation technology Medtronic plc (NYSE: MDT), a ...

November 20, 2023 | Monday | News
Hovione Acquires ExtremoChem for Biopharmaceutical Stabilization and Delivery

Hovione has acquired ExtremoChem Lda, a start-up company with a portfolio of rare sugars, synthetic analogues of the natural molecule...

November 17, 2023 | Friday | News
Vertex and CRISPR Therapeutics Granted Historic Approval for CASGEVY™, the World's First CRISPR/Cas9 Gene-Edited Therapy, by UK MHRA to Combat Sickle Cell Disease and Beta Thalassemia

 - First regulatory authorization of a CRISPR-based gene-editing therapy in the world – - CASGEVY is indicated for the treatment of sickle cell...

November 17, 2023 | Friday | News
T-Therapeutics Secures £48M in Series A for Advancing Next-Gen TCR Therapeutics in Cancer Treatment Transformation.

T-Therapeutics raises £48 million Series A for development of next generation TCR therapeutics to transform cancer treatment Fundraise led by Sofin...

November 16, 2023 | Thursday | News
QIAGEN Introduces TissueLyser III and RNeasy PowerMax Soil Pro Kit for Enhanced Sample Processing and RNA Isolation

QIAGEN announced the expansion of its sample technologies portfolio with the introduction of two new products aimed at supporting researchers in managing d...

November 16, 2023 | Thursday | News
£14.5 Million Funding Boost for Neurodegenerative Research Projects in the UK

Seven major research projects to receive more than £14 million to develop new tests, treatments and devices for neurodegenerative diseases includin...

November 14, 2023 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2023 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close